Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)

Size: px
Start display at page:

Download "Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)"

Transcription

1 Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Los Angeles, CA July 28th & 29th, :00 AM to 6:00 PM Price (Without Stay) Price: $1, (Seminar for One Delegate) Register now and save $200. (Early Bird) Barry A Friedman Consultant in Biotechnology, Regulatory Compliance and Aseptic Processing Arena **Please note the registration will be closed 2 days (48 Hours) prior to the date of the seminar. Barry A. Friedman, Ph.D., is a Senior Consultant in the Biotechnology, Regulatory Compliance, Microbiology and Aseptic Processing arena. From 2000 to 2007, Dr. Friedman was associated with Cambrex Bio Science Baltimore, a contract manufacturer of GMP bulk biopharmaceuticals located in Baltimore, MD. Overview: The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manufacturing process, and maintenance of the process in a state of control during routine commercial production.

2 Global CompliancePanel 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) AGENDA: Day One Day Two Lecture 1: Introduction; Goals and Objectives; Definitions Lecture 2: Process Validation - Its Importance within the Drug Industry Lecture 3: Interaction of the Three Stages with Process Validation Lecture 1: General Considerations for Process Validation - Stage 2 Process Qualification Lecture 2: Special Considerations for Process Validation - Stage 2 Lecture 4: Changes with the Commencement of Process Validation Lecture 3: General Considerations for Process Validation - Stage 3 Continued Process Verification Lecture 5: Validation Approaches Lecture 6: cgmps in Clinical Supply Manufacture Lecture 4: A Review of EU Annex 15 and its Comparison to FDA s Process Validation Guidance Lecture 7: Special Manufacturing Situations within Phase 1 Lecture 8: The Requirements for "Safe" Product within Stage 1 Lecture 5: Concurrent Release of Process performance Qualification (PPQ) Batches Lecture 9: The Requirements of Phase 1 Investigational Drug Requirement Lecture10: Regulatory Strategies for Phase 2 and 3 and their Incorporation within Stages 1 and 2 Lecture 11: Questions? Lecture 6: Analytical Methodology and Process Validation Lecture 7: Warning Letters Related to Process Validation Lecture 8: Questions? Why should you attend: The Process Validation Guidance for Industry was recently revised after many years. With the emphasis today on being able to assure that a process is meeting its requirements through Validation, and not simply through Verification or Qualification, an understanding of both its importance and how to accomplish this feat has come to the fore. In addition, with ICH Q9, Risk Management, involved in every aspect of our day to day operations, it becomes especially important to learn how this meshes with Process Validation. The FDA and especially CDER, with their new auditing format, will be wanting to understand how each Company performed their Validations in all areas to include manufacturing and Quality. Having an enhanced understanding of the Process Validation Guidance will assure that your firm is meeting the FDA s current requirements.

3 Global CompliancePanel 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Group Participation What You will get 10% 2 Attendees to get offer 1 Learning Objectives 20% 3 to 6 Attendees to get offer 2 Participation certificates 25% 7 to 10 Attendees to get offer 3 Interactive sessions with the US expert 30% 10+ Attendees to get offer 4 Post event assistance to your queries. Payment Option 5 Special price on future purchase of web based trainings. 1 2 Credit Card: Use the Link to make Payment by Visa/Master/American Express card click on the register now link Check: Kindly make the check payable to NetZealous DBA GlobalCompliancePanel and mailed to 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA 6 7 Special price on future consulting or expertise services. Special price on future seminars by GlobalCompliancePanel. 3 PO: Please drop an to or call the our toll free for the invoice and 8 Seminar Kit includes presentation handout, ID card, brochure, trainings catalog, notepad you may fax the PO to and pen. 4 Wire Transfer: Please drop an to or call our toll free for the wire transfer 9 Networking with industry's top notch professionals information Contact Information: Event Coordinator NetZealous LLC, DBA GlobalComplianePanel 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA Toll free: Fax: Kindly get in touch with us for any help or information. Look forward to meeting you at the seminar GlobalCompliancePanel

The A to Z's of Writing and Enforcing Effective SOPs

The A to Z's of Writing and Enforcing Effective SOPs Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: The A to Z's of Writing and Enforcing Effective SOPs Los Angeles, CA July 28th & 29th, 2016 9:00 AM to 6:00 PM Price (Without Stay)

More information

Construction: OSHA Construction Hazards for any Jobsite

Construction: OSHA Construction Hazards for any Jobsite Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Construction: OSHA Construction Hazards for any Jobsite Los Angeles, CA July 28th & 29th, 2016 Price Price: $1,295.00 (Seminar for

More information

HIPAA Security & Privacy Official - Roles and Responsibilities

HIPAA Security & Privacy Official - Roles and Responsibilities Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: HIPAA Security & Privacy Official - Roles and Responsibilities Houston, TX July 14th & 15th, 2016 9:00 AM to 6:00 PM Price (Without

More information

Validation and 21 CFR 11 Compliance of Computer Systems: Intermediate to Advanced

Validation and 21 CFR 11 Compliance of Computer Systems: Intermediate to Advanced Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Validation and 21 CFR 11 Compliance of Computer Systems: Intermediate to Advanced San Diego, CA July 14th & 15th, 2016 9:00 AM to

More information

Tax and Accounting Strategies for Residential Real Estate Investors

Tax and Accounting Strategies for Residential Real Estate Investors Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Tax and Accounting Strategies for Residential Real Estate Investors Chicago, IL July 21st & 22nd, 2016 9 AM to 6 PM Price Price:

More information

The A to Z's of HIPAA Compliance

The A to Z's of HIPAA Compliance Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: The A to Z's of HIPAA Compliance Chicago, IL July 21st & 22nd, 2016 Price Price: $1,295.00 (Seminar for One Delegate) 9:00 AM to

More information

Predicting & Improving Product Reliability

Predicting & Improving Product Reliability Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Predicting & Improving Product Reliability Boston, MA July 7th & 8th, 2016 9:00 AM to 6:00 PM Price Price: $1,295.00 (Seminar for

More information

Marketing Products Without Getting Hammered by FDA

Marketing Products Without Getting Hammered by FDA Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Marketing Products Without Getting Hammered by FDA Chicago, IL July 21st & 22nd, 2016 9:00 AM to 6:00 PM Price Price: $1,295.00

More information

Tools and Techniques for Operational Risk Management: Regulatory Aspects

Tools and Techniques for Operational Risk Management: Regulatory Aspects Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Tools and Techniques for Operational Risk Management: Regulatory Aspects San Diego, CA July 14th & 15th, 2016 Price Price: $1,295.00

More information

Tools and Techniques for Operational Risk Management: Regulatory Aspects

Tools and Techniques for Operational Risk Management: Regulatory Aspects Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Tools and Techniques for Operational Risk Management: Regulatory Aspects Chicago, IL July 21st & 22nd, 2016 Price Price: $1,295.00

More information

Payroll Fundamentals. Price. 2-day In-person Seminar: Los Angeles, CA. July 28th & 29th, 2016. 9:00 AM to 6:00 PM. Dayna J. Reum.

Payroll Fundamentals. Price. 2-day In-person Seminar: Los Angeles, CA. July 28th & 29th, 2016. 9:00 AM to 6:00 PM. Dayna J. Reum. Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Payroll Fundamentals Los Angeles, CA July 28th & 29th, 2016 9:00 AM to 6:00 PM Price Price: $895.00 (Seminar for One Delegate) Register

More information

Leadership and Team Development for Managerial Success

Leadership and Team Development for Managerial Success Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Leadership and Team Development for Managerial Success Chicago, IL July 21st & 22nd, 2016 Price Price: $995.00 (Seminar for One

More information

HIPAA for the Compliance Officer

HIPAA for the Compliance Officer Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: HIPAA for the Compliance Officer Chicago, IL July 21st & 22nd, 2016 9:00 AM to 6:00 PM Price (Without Stay) Price: $1,295.00 (Seminar

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time

More information

Pharmaceutical Quality Management System: Current Concept

Pharmaceutical Quality Management System: Current Concept Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Process Validation: General Principles and Practices U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center

More information

Guidance for Industry. Q10 Pharmaceutical Quality System

Guidance for Industry. Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

ICH Q10 Pharmaceutical Quality System (PQS)

ICH Q10 Pharmaceutical Quality System (PQS) ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives

More information

Computerised Systems in Analytical Laboratories

Computerised Systems in Analytical Laboratories ECA Certified Computer Validation Manager Course* New EU Annex 11 and Chapter 4 Requirements will be covered Computerised Systems in Analytical Laboratories Foto: DRK The Electronic Analytical GMP : Integrating

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE

More information

Lean Strategies for Laboratory Testing

Lean Strategies for Laboratory Testing Microrite, Inc. brings you this unique learning experience in Lean Strategies for Laboratory Testing; Part of Microrite s step-by-step webinar series. Lean Strategies for Laboratory Testing erience in

More information

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new

More information

Raleigh, NC May 12 th & 13 th 2016. Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply?

Raleigh, NC May 12 th & 13 th 2016. Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply? Raleigh, NC May 12 th & 13 th 2016 Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply? The International Cleanroom Standards (ISO 14644-1 & 2) have been updated, these

More information

Auditing as a Component of a Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a

More information

Electronic GMP Systems

Electronic GMP Systems Electronic GMP Systems Specification - Implementation Validation 18 20 March 2015, Prague, Czech Republic SPEAKERS: Kai Kiefer fme AG, Germany Dr Bob McDowall McDowall Consulting, UK LEARNING OBJECTIVES:

More information

[ABOUT THE AUTHOR. FDA Lifecycle Approach to Process Validation What, Why, and How? PQ Forum. Paul L. Pluta]

[ABOUT THE AUTHOR. FDA Lifecycle Approach to Process Validation What, Why, and How? PQ Forum. Paul L. Pluta] Paul L. Pluta] FDA Lifecycle Approach to Process Validation What, Why, and How? Paul L. Pluta PQ Forum provides a mechanism for validation practitioners to share information about Stage 2 process qualification

More information

How CMOs are Turning Their Training Programs into Market Differentiators

How CMOs are Turning Their Training Programs into Market Differentiators How CMOs are Turning Their Training Programs into Market Differentiators How CMOs are Turning Their Training Programs into Market Differentiators A Contract Manufacturing Organization (CMO) has as much

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

An Interactive Two-Day Program. Manufacturing and Quality Requirements for Biotech Drug Products to Meet the New Worldwide Requirements

An Interactive Two-Day Program. Manufacturing and Quality Requirements for Biotech Drug Products to Meet the New Worldwide Requirements An Interactive Two-Day Program Manufacturing and Quality Requirements for Biotech Drug Products to Meet the New Worldwide Requirements REGISTER EARLY! Mainz, Germany 13 14 October 2015 Hyatt Regency Mainz

More information

tdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L.

tdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L. SKILLS/SPECIAL QUALIFICATIONS: Regulatory Expertise: Technical Expertise: CAPT. (RET) TERRI L. DODDS - BSN, RN Former Public Health Service (PHS) Officer with 16 years of FDA experience in Pharmaceuticals,

More information

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

QbD / PAT Conference 2014

QbD / PAT Conference 2014 Invitation to The University of Heidelberg Authority Speakers: Karthik Iyer FDA, CDER, USA (via video conference) Dr Øyvind Holte Norwegian Medicines Agency Speakers from Industry and University: Sander

More information

Presented by Rosemarie Bell 24 April 2014

Presented by Rosemarie Bell 24 April 2014 Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April

More information

Monitoring. Compliant and Reasonable. 5-6 May 2015, Berlin, Germany

Monitoring. Compliant and Reasonable. 5-6 May 2015, Berlin, Germany Environmental Monitoring Workshops How to Establish an Environmental Monitoring Programme Interpretation of OOS Results Compliant and Reasonable 5-6 May 2015, Berlin, Germany SPEAKERS: Oxoid, UK Sauflon

More information

Practical Series Seminars and Workshops INTENSIVE TRAINING IN ENVIRONMENTAL MONITORING, DISINFECTANT QUALIFICATION AND CLEANROOM CONTAMINATION CONTROL

Practical Series Seminars and Workshops INTENSIVE TRAINING IN ENVIRONMENTAL MONITORING, DISINFECTANT QUALIFICATION AND CLEANROOM CONTAMINATION CONTROL QUALIFICATION AND CLEANROOM CONTAMINATION CONTROL Who should attend: Quality Assurance, Quality Control, Operations, Regulatory and Manufacturing Supervisors, Cleanroom Operators and Facilities Personnel

More information

An FDA Perspective on Post- Approval Change Management for PAT and RTRT

An FDA Perspective on Post- Approval Change Management for PAT and RTRT An FDA Perspective on Post- Approval Change Management for PAT and RTRT IFPAC 2015 January 26, 2015 Christine M. V. Moore, Ph.D. Acting Director, Process and Facilities FDA/CDER/OPQ Post-Approval Changes

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,

More information

2014 Annual Report on Inspections of Establishments

2014 Annual Report on Inspections of Establishments 2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered

More information

IMP management at site. Dmitry Semenyuta

IMP management at site. Dmitry Semenyuta IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

The Technical Compliance Manager

The Technical Compliance Manager The Technical Compliance Manager Avoiding Non-Compliance in the technical area 3-5 June 2014, Berlin, Germany SPEAKERS: Dr Gerhard Hauser European Hygienic Engineering and Design Group (EHEDG) Dr Jean

More information

Best Practice In A Change Management System

Best Practice In A Change Management System Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits

More information

2010 Critical Thinker Series

2010 Critical Thinker Series Malaysian Organisation of Pharmaceutical Industries (MOPI) & PharmEng Technology Presents cgmp Case Studies a T rra ini ing i P rrog rram ffo rr cgmp P rro ffe ss ss ionai l ss 2010 Critical Thinker Series

More information

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services.

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services. CONCEPT HEIDELBERG Pharmaceutical Quality Training. Conferences. Services. About Us Helping you to Comply with GMP Since our foundation on 1 April 1978, CONCEPT HEIDELBERG has been concentrating on providing

More information

Food and Drug Administration

Food and Drug Administration Center for Drug Evaluation and Research (CDER) Small Business Assistance Program The Information Source for Regulated Domestic and International Small Pharmaceutical Business CAPT Brenda Stodart, USPHS

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

Introduction to Q10 Pharmaceutical Quality System

Introduction to Q10 Pharmaceutical Quality System ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International

More information

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

The Quality System for Drugs in Germany

The Quality System for Drugs in Germany The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute

More information

How to implement a Quality Management System

How to implement a Quality Management System How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your

More information

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP5 - a lifecycle management framework for customized bioprocess solutions GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),

More information

QC Micro Webinar Series. Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA Solution

QC Micro Webinar Series. Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA Solution QC Micro Webinar Series Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA Solution Rapid Testing Solutions / Lonza / 07 Jun 2011 Today s Presenters Bob Toal Segment Manager, Informatics

More information

Clinical Trial Logistics

Clinical Trial Logistics Company Brochure Clinical Trial Logistics contents 1. 2. 3. 4. 5. 6. About us Values Facility Quality Management System Services Why PCS Clinical Trial Logistics about us MEET US PHARMA COMPLEX SOLUTIONS

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Email Retention. A Workshop on Email Retention Policies:- The risks, possible approaches and implementation issues

Email Retention. A Workshop on Email Retention Policies:- The risks, possible approaches and implementation issues Introduction Most inter- and intra-business communication takes place by email. The bases for critical decisions and contractual agreements are often only documented in email. Courts both in Europe and

More information

RAPS ONLINE UNIVERSITY

RAPS ONLINE UNIVERSITY RAPS ONLINE UNIVERSITY Practical education and training for business success. For regulatory professionals, there is only one name to know and trust for online education and training RAPS Online University.

More information

Good Cold Chain Management Practices for Clinical Trial Materials/Investigational Medicinal Products

Good Cold Chain Management Practices for Clinical Trial Materials/Investigational Medicinal Products Good Cold Chain Management Practices for Clinical Trial Materials/Investigational Medicinal Products Author: Rafik H. Bishara, Ph.D. Introduction The storage, handling, and distribution of temperature-sensitive

More information

The FDA recently announced a significant

The FDA recently announced a significant This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction

More information

Providing Trusted and Innovative Solutions t o the Life Science Communities

Providing Trusted and Innovative Solutions t o the Life Science Communities Providing Trusted and Innovative Solutions t o the Life Science Communities Eurogentec Eurogentec is a leading supplier of trusted and innovative reagents, kits, specialty products and custom research/development

More information

Safety Is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies

Safety Is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies Safety Is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies CLICK HERE to register. PROGRAM COMMITTEE WHO SHOULD ATTEND This program will benefit professionals with

More information

PEOPLE > SCIENCE > SOLUTIONS

PEOPLE > SCIENCE > SOLUTIONS PEOPLE > SCIENCE > SOLUTIONS Our difference Our foundation Our focus ANALYTICAL CHEMISTRY & MATERIALS CHARACTERIZATION EFFICACY (Functional testing) BIOCOMPATIBILITY (in vivo & in vitro toxicology) CLINICAL

More information

Biotechpharma company profile

Biotechpharma company profile Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing

More information

Harmonizing Change Control Processes Globally

Harmonizing Change Control Processes Globally Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses

More information

Streamlining clinical trial supply management

Streamlining clinical trial supply management Life Sciences Clinical Trial Supply Management Streamlining clinical trial supply management Driving faster, more effective clinical trials In this white paper A critical step of the development chain:

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Big Data Analysis & Data Mining

Big Data Analysis & Data Mining International Conference on Big Data Analysis & Data Mining Brochure Lexington, USA May 04-06, 2015 Conference Secretariat 5716 Corsa Ave., Suite 110, West Lake, Los Angeles, CA 91362-7354, USA Ph: +1-650-268-9744,

More information

Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products

Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products DRAFT GUIDANCE This guidance document

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 *QP Code of Practice 2008 updated Aug15 Page 1 of 13 Code of Practice for Qualified Persons 1. INTRODUCTION 2.

More information

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations This paper discusses the nuances of lifecycle validation implementation at contract manufacturing organizations (CMOs).

More information

Short Course. Certificate in Project Management (MBA Aligned)

Short Course. Certificate in Project Management (MBA Aligned) Short Course Certificate in Project Management (MBA Aligned) NQF Level: 9 9 to 12 February 2015 1. INTRODUCTION Within all business sectors today, there is a need for professionals who are capable of managing

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services

More information

Best Practices in Identity and Access Management (I&AM) for Regulatory Compliance. RSA Security and Accenture February 26, 2004 9:00 AM

Best Practices in Identity and Access Management (I&AM) for Regulatory Compliance. RSA Security and Accenture February 26, 2004 9:00 AM Best Practices in Identity and Access Management (I&AM) for Regulatory Compliance RSA Security and Accenture February 26, 2004 9:00 AM Agenda Laura Robinson, Industry Analyst, RSA Security Definition of

More information

2011 PDA Europe Modern Biopharmaceutical Manufacturing. 6-7 December 2011 ENSTBB Bordeaux, France. Current Best Practice

2011 PDA Europe Modern Biopharmaceutical Manufacturing. 6-7 December 2011 ENSTBB Bordeaux, France. Current Best Practice 6-7 December 011 ENSTBB Bordeaux, France The Parenteral Drug Association presents... 011 PDA Europe Modern Biopharmaceutical Manufacturing Register by 10 Oct 011 and SAVE! Current Best Practice Conference

More information

NEW CHEMICAL ENTITIES

NEW CHEMICAL ENTITIES NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product

More information

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data

More information

Regulatory Expectations of Executive Management

Regulatory Expectations of Executive Management Regulatory Expectations of Executive Management Steven Lynn, MS, CMQ/OE Director Office of Manufacturing and Product Quality Office of Compliance CDER/US FDA PDA ICH Q10 Executive Management Workshop PDA

More information

Pharmaceutical Engineering: The Lisbon Masters Program

Pharmaceutical Engineering: The Lisbon Masters Program EAFP Catania June 24-26, 26, 2010 Pharmaceutical Engineering: The Lisbon Masters Program José Menezes, Rogério Gaspar, João Bordado,, José Morais Technical University of Lisbon (Portugal) Faculty of Pharmacy,

More information

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of

More information

Use of MedDRA in CTCAE and in the Biopharmaceutical Industry

Use of MedDRA in CTCAE and in the Biopharmaceutical Industry Use of MedDRA in CTCAE and in the Biopharmaceutical Industry Ann Setser, BSN, MEd MedDRA MSSO MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations

More information

Guideline for Industry

Guideline for Industry Guideline for Industry The Extent of Population Exposure to Assess Clinical Safety: For Drugs Intended for Longterm Treatment of Non-Life- Threatening Conditions ICH-E1A March 1995 GUIDELINE FOR INDUSTRY

More information

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011

More information

LIBRARY GUIDE. Online Courses. March 2012

LIBRARY GUIDE. Online Courses. March 2012 LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................

More information

Workshop on process validation

Workshop on process validation Workshop on process validation General concepts on process validation Kowid Ho Scope / background Process evaluation/validation of biotechnology derived proteins used as active substance in the manufacture

More information

Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects

Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects U.S. Department of Health and Human Services Food and Drug Administration Center for Drug

More information

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality

More information

Pharmaceutical Quality Systems (ICH Q10) Conference. Business Case for Quality

Pharmaceutical Quality Systems (ICH Q10) Conference. Business Case for Quality Pharmaceutical Quality Systems (ICH Q10) Conference Business Case for Quality Jeffrey Macher, PhD Associate Professor McDonough School of Business Georgetown University Presentation Agenda Business Case

More information

In 2001, ISPE issued Baseline Guide Volume

In 2001, ISPE issued Baseline Guide Volume In today s biopharma and pharmaceutical industries, three related, but distinct terms are in common use: commissioning, qualification, and verification. Inconsistent interpretation and application of these

More information

POLICY AND PROCEDURES OFFICE OF PHARMACEUTICAL SCIENCE

POLICY AND PROCEDURES OFFICE OF PHARMACEUTICAL SCIENCE POLICY AND PROCEDURES OFFICE OF PHARMACEUTICAL SCIENCE CLARIFICATION TELECONFERENCES BETWEEN SPONSORS, APPLICANTS, OR MASTER FILE HOLDERS AND THE ONDQA REVIEW TEAM Table of Contents PURPOSE...1 BACKGROUND...2

More information

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9 Short Title: Full Title: APPROVED Management for Engineers Module Code: OPER H6001 Credits: 5 NFQ Level: 9 Field of Study: Mechanics and metal work Module Delivered in 1 programme(s) Reviewed By: GERARD

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information

Bachelor s Degree. in Manufacture of Medicinal Products (DT291) Full Time Part Time Online. www.getreskilled.com

Bachelor s Degree. in Manufacture of Medicinal Products (DT291) Full Time Part Time Online. www.getreskilled.com Bachelor s Degree in Manufacture of Medicinal Products (DT291) Full Time Part Time Online www.getreskilled.com Contents 1. Welcome 2. Program Overview 3. Program Content 4. Core Modules 5. Optional Modules

More information

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Risk-Based Environmental Monitoring Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Presenter Marsha Stabler Hardiman Over 20 years experience in the

More information

(COMPANY LOGO) CGMP COMPUTERIZED SYSTEM VENDOR AUDIT QUESTIONNAIRE

(COMPANY LOGO) CGMP COMPUTERIZED SYSTEM VENDOR AUDIT QUESTIONNAIRE 1. GENERAL COMPANY INFORMATION (COMPANY LOGO) 1.1 Name Address Years in Business Number of Employees Services Performed or Products Manufactured Prior Experience with (Company Name) 1.2 Please provide

More information